InsidersTradesSigma
Track the Amerisourcebergen CORP share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Amerisourcebergen CORP has logged 160 reports. The latest transaction was disclosed on 9 August 2023 (Levée d'options). Among the most active insiders: COLLIS STEVEN H. The full history is free.
160
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€4bn
20 ops.
Sell Volume
27Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 August 2023
Declarations160 total
10,499 shares@ US$77.531.3% of flowCommon StockSEC:0001140859-23-000120:0
1,320,858 shares@ US$189.2715.5% of flowCommon StockSEC:0000899243-23-017819:0
166 shares@ US$189.1010.2% of flowCommon StockSEC:0001140859-23-000118:0
10,499 shares@ US$77.531.3% of flowCommon StockSEC:0001140859-23-000110:0
73.365 shares@ US$163.5660.3% of flowCommon StockSEC:0001140859-23-000108:0
61.443 shares@ US$163.5660.9% of flowCommon StockSEC:0001140859-23-000106:0
87.121 shares@ US$163.5661.4% of flowCommon StockSEC:0001140859-23-000104:0
534 shares@ US$192.4310.3% of flowCommon StockSEC:0001140859-23-000102:1
1,432 shares0Common StockSEC:0001140859-23-000102:0
27,542 shares@ US$77.5328.5% of flowCommon StockSEC:0001140859-23-000100:0
275,984 shares@ US$181.171.1% of flowCommon StockSEC:0000899243-23-015912:0
10,499 shares@ US$77.531.4% of flowCommon StockSEC:0001140859-23-000096:0
3,305 shares@ US$77.5322.1% of flowCommon StockSEC:0001140859-23-000090:0
38,376 shares@ US$75.61100.0% of flowCommon StockSEC:0001140859-23-000092:0
292,792 shares@ US$170.771.1% of flowCommon StockSEC:0000899243-23-012969:0
10,499 shares@ US$77.531.3% of flowCommon StockSEC:0001140859-23-000088:0
188 shares@ US$166.7910.2% of flowCommon StockSEC:0001140859-23-000086:0
10,499 shares@ US$77.531.3% of flowCommon StockSEC:0001140859-23-000079:0
10,499 shares@ US$77.531.4% of flowCommon StockSEC:0001140859-23-000076:0
1,334 sharesCommon StockSEC:0001140859-23-000071:0
1,334 sharesCommon StockSEC:0001140859-23-000068:0
1,334 sharesCommon StockSEC:0001140859-23-000073:0
1,667 sharesCommon StockSEC:0001140859-23-000066:0
1,211 sharesCommon StockSEC:0001140859-23-000065:0
1,334 sharesCommon StockSEC:0001140859-23-000070:0
25 of 160 declarations
关于 Amerisourcebergen CORP
AmerisourceBergen Corp.（股票代码 ABC）现已成为美国主要的药品分销和医疗保健服务平台之一，在美国纽约证券交易所上市。该公司于2001年由 AmeriSource Health Corporation 和 Bergen Brunswig Corporation 合并而成。它后来于2023年更名为 Cencora，同时保留了其原有的运营足迹及其在药品供应链中的核心作用。其全球总部位于宾夕法尼亚州康肖霍肯，费城地区。（[investor.cencora.com](https://investor.cencora.com/news/news-details/2001/Amerisource-And-Bergen-Brunswig-Merge-To-Create-New-Industry-Leader-Amerisourcebergen/default.aspx?utm_source=openai)) 从业务角度来看，该公司围绕药品分销和支持制造商、药房、医疗系统、医生诊所及其他护理机构的邻近服务而构建。其业务组合包括药品批发分销、专业分销、专业物流、制造商服务、咨询和商业化支持。Cencora 还强调其在动物健康领域的业务，这使得该平台超越了人类医疗保健，并为其带来了额外的终端市场多元化。（[cencora.com](https://www.cencora.com/about?utm_source=openai)) 在竞争方面，AmerisourceBergen 受益于其在行业中的规模，在该行业中，网络密度、运营可靠性和长期的客户关系是重要的进入壁垒。该公司指出其在美国拥有广泛的分销网络，在50多个国家拥有本地和全球业务，客户群涵盖医疗系统、社区药房和其他护理提供商。这种规模使其成为获取治疗药物的关键基础设施合作伙伴，尤其是在专业药品、生物仿制药和更复杂的治疗模式方面。（[cencora.com](https://www.cencora.com/cencora-ventures/about-cencora?utm_source=openai)) 最近的里程碑突显了其持续向价值链上游移动。在2025年末，Cencora 宣布了一项到2030年的1 billion美元投资计划，旨在加强其美国分销网络，扩大产能，并提高供应链韧性，特别是针对专业药品和冷链能力。在其2025财年年终业绩中，该公司报告了收入增长，并表示通过收购 Retina Consultants of America (RCA) 巩固了其专业地位。它还概述了自2026财年起生效的报告结构重组，反映了更清晰的战略重点。（[investor.cencora.com](https://investor.cencora.com/news/news-details/2025/Cencora-Reports-Fiscal-2025-Fourth-Quarter-and-Fiscal-Year-End-Results/default.aspx)) 对于投资者而言，ABC 将防御性医疗保健分销特征与专业制药增长、物流投资以及美国药品供应链的结构重要性相结合。它最好被理解为一项关键任务的医疗保健基础设施业务，而非纯粹的制药制造商，其收益和运营势头受分销量、产品组合、服务扩展和监管动态的影响。（[investor.cencora.com](https://investor.cencora.com/news/news-details/2025/Cencora-Reports-Fiscal-2025-Fourth-Quarter-and-Fiscal-Year-End-Results/default.aspx))
